Neuropathic Pain Market Report 2026
Download Free Sample Buy Now
Neuropathic Pain Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Neuropathic Pain Market Report 2026

Global Outlook – By Treatment (Medications, Multimodal Therapy), By Diagnosis (Imaging, Blood Tests And Physical Examination), By Indication (Diabetic Neuropathy, Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Other Indications), By End User (Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Neuropathic Pain Market Overview

• Neuropathic Pain market size has reached to $5.78 billion in 2025

• Expected to grow to $8.48 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%

• Growth Driver: Rising Prevalence Of Chronic Pain Drives Growth In The Neuropathic Pain Market

• Market Trend: Integration Of Artificial Intelligence Revolutionizes Neuropathic Pain Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Neuropathic Pain Market?

Neuropathic pain is chronic pain caused by damage or dysfunction in the nervous system and characterized by burning, tingling, shooting, or electric shock-like sensations. Neuropathic pain can be challenging to treat and may be caused by nerve injuries, diabetes, multiple sclerosis, nerve compression, neural degeneration and central nervous system disorders.

The main types of neuropathic pain treatment are medications and multimodal therapy. Medications involve the use of pharmaceutical substances to alleviate symptoms or manage conditions and certain medications, such as anticonvulsants, antidepressants and opioids, can target nerve-related abnormalities and pathways, reducing the intensity of neuropathic pain signals and providing relief. Neuropathic pain is diagnosed by imaging, blood tests and physical examination procedures indicated for diabetic neuropathy, spinal stenosis, chemotherapy-induced peripheral neuropathy and others provided by hospitals, clinics, home healthcare, ambulatory surgical centers and others.

Neuropathic Pain Market Global Report 2026 Market Report bar graph

What Is The Neuropathic Pain Market Size and Share 2026?

The neuropathic pain market size has grown strongly in recent years. It will grow from $5.78 billion in 2025 to $6.2 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to rising prevalence of diabetes, early adoption of antidepressants and anticonvulsants, increased awareness of neuropathic pain conditions, development of opioid-based treatments, initial use of imaging for diagnosis.

What Is The Neuropathic Pain Market Growth Forecast?

The neuropathic pain market size is expected to see strong growth in the next few years. It will grow to $8.48 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to growing shift toward non-opioid therapies, rising demand for personalized pain management, expansion of complementary therapy usage, increasing investment in diagnostic innovations, development of advanced multimodal treatment solutions. Major trends in the forecast period include rising adoption of multimodal therapy approaches, increasing demand for non-opioid pain management, growing use of physical and psychological therapy integration, expansion of early diagnosis through imaging techniques, increasing focus on diabetic neuropathy treatment.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Neuropathic Pain Market Segmentation

1) By Treatment: Medications, Multimodal Therapy

2) By Diagnosis: Imaging, Blood Tests And Physical Examination

3) By Indication: Diabetic Neuropathy, Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Other Indications

4) By End User: Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Medications: Anticonvulsants, Antidepressants, Opioids, Topical Treatments, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

2) By Multimodal Therapy: Combination Of Medications, Physical Therapy, Psychological Therapy, Lifestyle Modifications, Complementary Therapies

What Is The Driver Of The Neuropathic Pain Market?

The rising prevalence of chronic pain is expected to propel the growth of the neuropathic pain market going forward. Chronic pain is defined as persistent discomfort lasting three months or more it affects a substantial portion of the population and significantly impacts quality of life. The increase in chronic pain cases is driven by factors such as aging populations, nerve damage, and chronic illnesses like diabetes. Neuropathic pain therapies support public health by targeting nerve dysfunction, relieving symptoms, and improving patients’ daily functioning. For instance, in November 2024, according to the data published by the Centers for Disease Control and Prevention (CDC), a US-based nation's health protection agency, adult populations experienced 24.3% prevalence of chronic pain and 8.5% prevalence of high-impact chronic pain in 2023 equivalent to 34.9% among those with chronic pain with women, American Indian and Alaska Native adults, and individuals aged 65 years and older showing notably higher rates. Therefore, the rising prevalence of chronic pain is driving the neuropathic pain industry.

Key Players In The Global Neuropathic Pain Market

Major companies operating in the neuropathic pain market are Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline Plc, Medtronic Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Boston Scientific Corporation, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Grünenthal GmbH, Lupin Ltd., Nevro Corp., InvaGen Pharmaceuticals Inc, Centaur Pharmaceuticals Pvt Ltd., Stimwave LLC, Novartis AG, Astellas Pharma Inc., Vertex Pharmaceuticals Incorporated, Assertio Therapeutics Inc, NeuroMetrix Inc, OMRON Healthcare Co Ltd

Global Neuropathic Pain Market Trends and Insights

Major companies operating in the neuropathic pain market are adopting artificial intelligence technologies for advanced diagnosis, tailored treatment plans, real-time monitoring, drug discovery and data-driven insights to enhance patient outcomes and refine pain management strategies. For instance, in March 2023, Nevro Corp., a US-based medical device company, launched the Senza HFX iQ spinal cord stimulation (SCS) system. This innovative technology employs artificial intelligence (AI) to customize pain relief for individual patients. The system, which includes the HFX iQ Implantable Pulse Generator (IPG), HFX Trial Stimulator, Charger and HFX App, is designed to treat non-surgical back pain and painful diabetic neuropathy by adapting to patient responses and feedback. It uses a unique algorithm based on extensive patient data and allows patients to adjust their pain relief program via a smartphone app. The system's digital environment enables data collection and potential updates. The technology aims to enhance pain relief through consistency and personalization, marking a significant advance in SCS therapy.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Neuropathic Pain Market?

In July 2023, Novartis AG, a Switzerland-based multinational pharmaceutical corporation focused on innovative medicines, acquired DTx Pharma for an undisclosed amount. This acquisition allows Novartis to utilize DTx's expertise in small interfering ribonucleic acid (siRNA) therapies for neurological disorders, enhancing its capacity to meet unmet medical needs and expediting the introduction of innovative treatments for patients. DTx Pharma is a US-based preclinical biotechnology company that develops RNA-based therapies for neuropathic pain.

Regional Outlook

North America was the largest region in the neuropathic pain market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neuropathic Pain Market?

The neuropathic pain market consists of revenues earned by entities by providing physical therapy services, acupuncture services and relaxation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuropathic pain market also includes sales of anticonvulsants, antidepressants, opioids, topical creams and transcutaneous electrical nerve stimulation devices, which are used in providing neuropathic pain diagnosis and treatment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neuropathic Pain Market Report 2026?

The neuropathic pain market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neuropathic pain industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Neuropathic Pain Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $6.2 billion
Revenue Forecast In 2035 $8.48 billion
Growth Rate CAGR of 7.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment, Diagnosis, Indication, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline Plc, Medtronic Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Boston Scientific Corporation, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Grünenthal GmbH, Lupin Ltd., Nevro Corp., InvaGen Pharmaceuticals Inc, Centaur Pharmaceuticals Pvt Ltd., Stimwave LLC, Novartis AG, Astellas Pharma Inc., Vertex Pharmaceuticals Incorporated, Assertio Therapeutics Inc, NeuroMetrix Inc, OMRON Healthcare Co Ltd
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Neuropathic Pain Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Neuropathic Pain Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Neuropathic Pain Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Neuropathic Pain Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences

4.1.5 Autonomous Systems, Robotics & Smart Mobility

4.2. Major Trends

4.2.1 Rising Adoption Of Multimodal Therapy Approaches

4.2.2 Increasing Demand For Non-Opioid Pain Management

4.2.3 Growing Use Of Physical And Psychological Therapy Integration

4.2.4 Expansion Of Early Diagnosis Through Imaging Techniques

4.2.5 Increasing Focus On Diabetic Neuropathy Treatment

5. Neuropathic Pain Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Home Healthcare Providers

5.4 Ambulatory Surgical Centers

5.5 Pain Management Centers

6. Neuropathic Pain Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neuropathic Pain Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Neuropathic Pain PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Neuropathic Pain Market Size, Comparisons And Growth Rate Analysis

7.3. Global Neuropathic Pain Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Neuropathic Pain Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neuropathic Pain Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neuropathic Pain Market Segmentation

9.1. Global Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Medications, Multimodal Therapy

9.2. Global Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Imaging, Blood Tests And Physical Examination

9.3. Global Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diabetic Neuropathy, Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Other Indications

9.4. Global Neuropathic Pain Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Other End Users

9.5. Global Neuropathic Pain Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anticonvulsants, Antidepressants, Opioids, Topical Treatments, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

9.6. Global Neuropathic Pain Market, Sub-Segmentation Of Multimodal Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Combination Of Medications, Physical Therapy, Psychological Therapy, Lifestyle Modifications, Complementary Therapies

10. Neuropathic Pain Market Regional And Country Analysis

10.1. Global Neuropathic Pain Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Neuropathic Pain Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neuropathic Pain Market

11.1. Asia-Pacific Neuropathic Pain Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neuropathic Pain Market

12.1. China Neuropathic Pain Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neuropathic Pain Market

13.1. India Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neuropathic Pain Market

14.1. Japan Neuropathic Pain Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neuropathic Pain Market

15.1. Australia Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neuropathic Pain Market

16.1. Indonesia Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neuropathic Pain Market

17.1. South Korea Neuropathic Pain Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neuropathic Pain Market

18.1. Taiwan Neuropathic Pain Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neuropathic Pain Market

19.1. South East Asia Neuropathic Pain Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neuropathic Pain Market

20.1. Western Europe Neuropathic Pain Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neuropathic Pain Market

21.1. UK Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neuropathic Pain Market

22.1. Germany Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neuropathic Pain Market

23.1. France Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neuropathic Pain Market

24.1. Italy Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neuropathic Pain Market

25.1. Spain Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neuropathic Pain Market

26.1. Eastern Europe Neuropathic Pain Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neuropathic Pain Market

27.1. Russia Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neuropathic Pain Market

28.1. North America Neuropathic Pain Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neuropathic Pain Market

29.1. USA Neuropathic Pain Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neuropathic Pain Market

30.1. Canada Neuropathic Pain Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neuropathic Pain Market

31.1. South America Neuropathic Pain Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neuropathic Pain Market

32.1. Brazil Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neuropathic Pain Market

33.1. Middle East Neuropathic Pain Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neuropathic Pain Market

34.1. Africa Neuropathic Pain Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Neuropathic Pain Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neuropathic Pain Market Regulatory and Investment Landscape

36. Neuropathic Pain Market Competitive Landscape And Company Profiles

36.1. Neuropathic Pain Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Neuropathic Pain Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Neuropathic Pain Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

37. Neuropathic Pain Market Other Major And Innovative Companies

GlaxoSmithKline Plc, Medtronic Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Boston Scientific Corporation, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Grünenthal GmbH, Lupin Ltd., Nevro Corp., InvaGen Pharmaceuticals Inc, Centaur Pharmaceuticals Pvt Ltd., Stimwave LLC, Novartis AG, Astellas Pharma Inc.

38. Global Neuropathic Pain Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neuropathic Pain Market

40. Neuropathic Pain Market High Potential Countries, Segments and Strategies

40.1 Neuropathic Pain Market In 2030 - Countries Offering Most New Opportunities

40.2 Neuropathic Pain Market In 2030 - Segments Offering Most New Opportunities

40.3 Neuropathic Pain Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Neuropathic Pain Market, Overview Of Key Products - Product Examples
  • Table 2: Global Neuropathic Pain Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Neuropathic Pain Market, Supply Chain Analysis
  • Table 4: Global Neuropathic Pain Market, Major Raw Material Providers
  • Table 5: Global Neuropathic Pain Market, Major Resource Providers
  • Table 6: Global Neuropathic Pain Market, Major Manufacturers (Suppliers)
  • Table 7: Global Neuropathic Pain Market, Major Distributors And Channel Partners
  • Table 8: Global Neuropathic Pain Market, Key Technologies & Future Trends
  • Table 9: Global Neuropathic Pain Market, Major Trends
  • Table 10: Global Neuropathic Pain Market, Major End Users
  • Table 11: Global Neuropathic Pain Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Neuropathic Pain Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Neuropathic Pain Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Neuropathic Pain Market - TAM, US$ Billion, 2025
  • Table 15: Global Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Neuropathic Pain Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Neuropathic Pain Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Neuropathic Pain Market, Sub-Segmentation Of Multimodal Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Neuropathic Pain Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Neuropathic Pain Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Neuropathic Pain Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Neuropathic Pain Market - Company Scoring Matrix
  • Table 97: Pfizer Inc. Financial Performance
  • Table 98: Johnson & Johnson Private Limited Financial Performance
  • Table 99: Sanofi S.A. Financial Performance
  • Table 100: Bristol-Myers Squibb Company Financial Performance
  • Table 101: Abbott Laboratories Financial Performance
  • Table 102: Global Neuropathic Pain Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Neuropathic Pain Market, Competitive Dashboard
  • Table 104: Global Neuropathic Pain Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Neuropathic Pain Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 106: Global, Neuropathic Pain Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Table 107: Global, Neuropathic Pain Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

List Of Figures

    Figure 1: Global Neuropathic Pain Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Neuropathic Pain Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Neuropathic Pain Market, Supply Chain Analysis
  • Figure 4: Global Neuropathic Pain Market, Major Raw Material Providers
  • Figure 5: Global Neuropathic Pain Market, Major Resource Providers
  • Figure 6: Global Neuropathic Pain Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Neuropathic Pain Market, Major Distributors And Channel Partners
  • Figure 8: Global Neuropathic Pain Market, Key Technologies & Future Trends
  • Figure 9: Global Neuropathic Pain Market, Major Trends
  • Figure 10: Global Neuropathic Pain Market, Major End Users
  • Figure 11: Global Neuropathic Pain Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Neuropathic Pain Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Neuropathic Pain Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Neuropathic Pain Market - TAM, US$ Billion, 2025
  • Figure 15: Global Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Neuropathic Pain Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Neuropathic Pain Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Neuropathic Pain Market, Sub-Segmentation Of Multimodal Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Neuropathic Pain Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Neuropathic Pain Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Neuropathic Pain Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Neuropathic Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Neuropathic Pain Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Neuropathic Pain Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Neuropathic Pain Market - Company Scoring Matrix
  • Figure 97: Pfizer Inc. Financial Performance
  • Figure 98: Johnson & Johnson Private Limited Financial Performance
  • Figure 99: Sanofi S.A. Financial Performance
  • Figure 100: Bristol-Myers Squibb Company Financial Performance
  • Figure 101: Abbott Laboratories Financial Performance
  • Figure 102: Global Neuropathic Pain Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Neuropathic Pain Market, Competitive Dashboard
  • Figure 104: Global Neuropathic Pain Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Neuropathic Pain Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 106: Global, Neuropathic Pain Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Figure 107: Global, Neuropathic Pain Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Read More About Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Read More About Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Read More About Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Chondroplasty Market Report 2026 - Global Outlook – By Type (Radiofrequency Ablation Chondroplasty, Abrasion Chondroplasty, Patellar Chondroplasty, Tissue Removal, Other Types), By Anatomy (Knee, Shoulder, Hip, Other Ana...

Research Department Explosive (RDX) Market Report 2026 - Global Outlook – By Type (RDX Powder Or Crystalline RDX, RDX-Based Compositions, RDX-Based Detonating Components, Other RDX Formulations), By Application (Military...

Cut Flowers Market Report 2026 - Global Outlook – By Flower Type (Rose, Chrysanthemum, Carnation, Gerbera, Lilium, Other Flower Types), By Application (Personal Use, Parties And Special Days, Wedding And Mega Cultural Ev...

Fire Truck Market Report 2026 - Global Outlook – By Product (Aerial Ladder Trucks, Aerial Platform Trucks, Other Products), By Propulsion Type (Internal Combustion Engine (ICE), Electric), By Application (Residential And...

Clinical Trial Imaging Market Report 2026 - Global Outlook – By Product And Services (Services, Software), By Modality (Computed Tomography, Magnetic Resonance Imaging, Echocardiography, Nuclear Medicine, Positron Emissi...

Custom Procedure Kits Market Report 2026 - Global Outlook – By Procedure (Colorectal, Thoracic, Orthopedic, Ophthalmology, Neurosurgery, Cardiac Surgery, Gynecology, General Surgery, Urology), By Product (Disposable, Reu...

RNA Targeting Small Molecules Therapeutics Market Report 2026 - Global Outlook – By Offering (mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonuclei...

Dermatitis Market Report 2026 - Global Outlook – By Drug Class (Corticosteroids, Emollients Or Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors ), By Distributio...

Frequently Asked Questions

The Neuropathic Pain market was valued at $5.78 billion in 2025, increased to $6.2 billion in 2026, and is projected to reach $8.48 billion by 2030.

The global Neuropathic Pain market is expected to grow at a CAGR of 8.1% from 2026 to 2035 to reach $8.48 billion by 2035.

Some Key Players in the Neuropathic Pain market Include, Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Bristol‑Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline Plc, Medtronic Inc., Eli Lilly and Company, Teva Pharmaceutical In

Major trend in this market includes: Integration Of Artificial Intelligence Revolutionizes Neuropathic Pain Treatment. For further insights on this market. request a sample here

North America was the largest region in the neuropathic pain market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuropathic pain market report are Asia-Pacific, South

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us